Skip to main content
. 2013 Jul 29;208(9):1464–1473. doi: 10.1093/infdis/jit352

Figure 1.

Figure 1.

Pharmacokinetic variability in 142 patients. In most instances, except for pyrazinamide 24-hour area under the concentration–time curve (AUC), the pharmacokinetic parameters were not normally distributed, as demonstrated by P < .05. The figures demonstrate the wide variability in the peak concentration and AUC. No concentrations of one drug covaried with that of another.